Cytokine signatures in hereditary fever syndromes (HFS)
Highlights • The current review reports a number of advances in the field of inflammatory/immunological mechanisms underlying HFS, and presents all available data regarding the cytokines’ signatures in HFS at the transcriptional, serum and ex vivo levels. • It also integrates recent data in an updat...
Saved in:
Published in | Cytokine & growth factor reviews Vol. 33; pp. 19 - 34 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.02.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Highlights • The current review reports a number of advances in the field of inflammatory/immunological mechanisms underlying HFS, and presents all available data regarding the cytokines’ signatures in HFS at the transcriptional, serum and ex vivo levels. • It also integrates recent data in an updated classification of the different HFS in which CAPS, NLRP12AD and FMF were now classified as inflammasomopathies, HIDS/MKD as metabolic dysregulation leading to IL-1β secretion, and TRAPS and the last HFS identified to date, TRAPS11, as protein misfolding disorders. • Cytokine signatures obtained in patients’ cells cultured ex vivo are much more convincing than results obtained at the transcriptional levels or in sera. • Elevated levels of acute phase reactants and pro-inflammatory cytokines in remission periods confirm the involvement of the cytokine network in the inflammatory process and provide evidence for the ongoing subclinical inflammation during asymptomatic periods of HFS. • The marked increase of IL-1β production by LPS-stimulated PBMCs observed in CAPS and NLRP12AD, but also in FMF and MKD, is a hallmark of these disorders. |
---|---|
ISSN: | 1359-6101 1879-0305 |
DOI: | 10.1016/j.cytogfr.2016.11.001 |